Cargando…

Synthesis and characterization of rod-like amino acids/nanohydroxyapatite composites to inhibit osteosarcoma

In this study, rod-like hydroxyapatite (HA) with uniform morphology and controllable particle size modified by doping with two different amino acids (alanine and threonine) was synthesized by a microwave hydrothermal method. The physical and chemical properties of the composites were tested by utili...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhengxiong, Wang, Xinyu, Luo, Jing, Zhang, Bowen, Shen, Fei, Li, Binbin, Yang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756758/
https://www.ncbi.nlm.nih.gov/pubmed/36545101
http://dx.doi.org/10.1039/d2ra03784j
_version_ 1784851687100383232
author Chen, Zhengxiong
Wang, Xinyu
Luo, Jing
Zhang, Bowen
Shen, Fei
Li, Binbin
Yang, Jing
author_facet Chen, Zhengxiong
Wang, Xinyu
Luo, Jing
Zhang, Bowen
Shen, Fei
Li, Binbin
Yang, Jing
author_sort Chen, Zhengxiong
collection PubMed
description In this study, rod-like hydroxyapatite (HA) with uniform morphology and controllable particle size modified by doping with two different amino acids (alanine and threonine) was synthesized by a microwave hydrothermal method. The physical and chemical properties of the composites were tested by utilizing X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), general thermogravimetric analysis (TG) and scanning electron microscopy (SEM). The SEM and XRD results show that the presence of amino acids (especially threonine) can significantly reduce the aspect ratio and crystallinity of hydroxyapatite. Pure hydroxyapatite and modified hydroxyapatite doped with two different proportions of amino acids were cultured with mouse osteoblasts (MC3T3-E1) for 1, 3 and 5 days, respectively, nanohydroxyapatite modified by threonine has better biocompatibility compared with pure hydroxyapatite. The amino acid-modified hydroxyapatite samples were co-cultured with osteosarcoma cells (MG63) for 1, 4 and 7 days, respectively, and showed better inhibitory effects on osteosarcoma cells. The nanohydroxyapatite doped with amino acids could be used as a potential drug that promotes bone repair and inhibits the growth of osteosarcoma cells.
format Online
Article
Text
id pubmed-9756758
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-97567582022-12-20 Synthesis and characterization of rod-like amino acids/nanohydroxyapatite composites to inhibit osteosarcoma Chen, Zhengxiong Wang, Xinyu Luo, Jing Zhang, Bowen Shen, Fei Li, Binbin Yang, Jing RSC Adv Chemistry In this study, rod-like hydroxyapatite (HA) with uniform morphology and controllable particle size modified by doping with two different amino acids (alanine and threonine) was synthesized by a microwave hydrothermal method. The physical and chemical properties of the composites were tested by utilizing X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), general thermogravimetric analysis (TG) and scanning electron microscopy (SEM). The SEM and XRD results show that the presence of amino acids (especially threonine) can significantly reduce the aspect ratio and crystallinity of hydroxyapatite. Pure hydroxyapatite and modified hydroxyapatite doped with two different proportions of amino acids were cultured with mouse osteoblasts (MC3T3-E1) for 1, 3 and 5 days, respectively, nanohydroxyapatite modified by threonine has better biocompatibility compared with pure hydroxyapatite. The amino acid-modified hydroxyapatite samples were co-cultured with osteosarcoma cells (MG63) for 1, 4 and 7 days, respectively, and showed better inhibitory effects on osteosarcoma cells. The nanohydroxyapatite doped with amino acids could be used as a potential drug that promotes bone repair and inhibits the growth of osteosarcoma cells. The Royal Society of Chemistry 2022-12-16 /pmc/articles/PMC9756758/ /pubmed/36545101 http://dx.doi.org/10.1039/d2ra03784j Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Chemistry
Chen, Zhengxiong
Wang, Xinyu
Luo, Jing
Zhang, Bowen
Shen, Fei
Li, Binbin
Yang, Jing
Synthesis and characterization of rod-like amino acids/nanohydroxyapatite composites to inhibit osteosarcoma
title Synthesis and characterization of rod-like amino acids/nanohydroxyapatite composites to inhibit osteosarcoma
title_full Synthesis and characterization of rod-like amino acids/nanohydroxyapatite composites to inhibit osteosarcoma
title_fullStr Synthesis and characterization of rod-like amino acids/nanohydroxyapatite composites to inhibit osteosarcoma
title_full_unstemmed Synthesis and characterization of rod-like amino acids/nanohydroxyapatite composites to inhibit osteosarcoma
title_short Synthesis and characterization of rod-like amino acids/nanohydroxyapatite composites to inhibit osteosarcoma
title_sort synthesis and characterization of rod-like amino acids/nanohydroxyapatite composites to inhibit osteosarcoma
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756758/
https://www.ncbi.nlm.nih.gov/pubmed/36545101
http://dx.doi.org/10.1039/d2ra03784j
work_keys_str_mv AT chenzhengxiong synthesisandcharacterizationofrodlikeaminoacidsnanohydroxyapatitecompositestoinhibitosteosarcoma
AT wangxinyu synthesisandcharacterizationofrodlikeaminoacidsnanohydroxyapatitecompositestoinhibitosteosarcoma
AT luojing synthesisandcharacterizationofrodlikeaminoacidsnanohydroxyapatitecompositestoinhibitosteosarcoma
AT zhangbowen synthesisandcharacterizationofrodlikeaminoacidsnanohydroxyapatitecompositestoinhibitosteosarcoma
AT shenfei synthesisandcharacterizationofrodlikeaminoacidsnanohydroxyapatitecompositestoinhibitosteosarcoma
AT libinbin synthesisandcharacterizationofrodlikeaminoacidsnanohydroxyapatitecompositestoinhibitosteosarcoma
AT yangjing synthesisandcharacterizationofrodlikeaminoacidsnanohydroxyapatitecompositestoinhibitosteosarcoma